abrdn Life Sciences Investors
HQL
62 hedge funds and large institutions have $82.2M invested in abrdn Life Sciences Investors in 2020 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 29 increasing their positions, 11 reducing their positions, and 13 closing their positions.
164% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 11
1% more capital invested
Capital invested by funds: $81.3M → $82.2M (+$844K)
0.6% more ownership
Funds ownership: 19.28% → 19.87% (+0.6%)
11% less funds holding
Funds holding: 70 → 62 (-8)
54% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAM
Advisors Asset Management
Monument,
Colorado
|
+$1.18M |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$789K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$728K |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$666K |
| 5 |
UR
USCA RIA
Houston,
Texas
|
+$626K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KIM
Karpus Investment Management
Pittsford,
New York
|
-$1.17M |
| 2 |
AWM
AE Wealth Management
Topeka,
Kansas
|
-$679K |
| 3 |
CRC
Curi RMB Capital
Chicago,
Illinois
|
-$661K |
| 4 |
SS
Simplicity Solutions
Minneapolis,
Minnesota
|
-$588K |
| 5 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
-$305K |
HQL Hedge Fund Activity: Q3 2020 in Review
62 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q3 2020, worth a combined $82.2M — up 1% from $81.3M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of HQL and 6 opened new positions — a net loss of 7 holders — while 11 trimmed existing stakes and 29 added.
The largest buyer was Advisors Asset Management, adding an estimated $1.18M. The largest seller was Karpus Investment Management, exiting entirely with an estimated $1.17M sold.
- 62 institutional investors held abrdn Life Sciences Investors (HQL) as of Q3 2020, down from 70 in Q2 2020.
- Funds reported $82.2M of abrdn Life Sciences Investors stock for Q3 2020, up 1% quarter-over-quarter.
- 6 funds opened new abrdn Life Sciences Investors positions in Q3 2020 and 13 closed out, a net change of -7 holders.
- The largest abrdn Life Sciences Investors buyer in Q3 2020 was Advisors Asset Management, an estimated $1.18M added.
- The largest abrdn Life Sciences Investors seller in Q3 2020 was Karpus Investment Management, an estimated $1.17M sold.
Based on aggregated 13F filings for Q3 2020.